| Mediterranean Diet Rich in Olive oil and Obesity, Metabolic Syndrome and Diabetes Mellitus. | |
| | |
MedLine Citation:
|
PMID: 21443484 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
After decades of epidemiological, clinical and experimental research, it has become clear that consumption of Mediterranean dietary patterns rich in olive oil have a profound influence on health outcomes, including obesity, metabolic syndrome (MetS) and diabetes mellitus. Traditionally, many beneficial properties associated with this oil have been ascribed to its high oleic acid content. Olive oil, however, is a functional food that, besides having high-monounsaturated (MUFA) content, contains other minor components with biological properties. In this line, phenolic compounds have shown antioxidant and antiinflammatory properties, prevent lipoperoxidation, induce favorable changes of lipid profile, improve endothelial function, and disclose antithrombotic properties. Research into the pharmacological properties of the minor components of olive oil is very active and could lead to the formulation of functional food and nutraceuticals. Although more data are mandatory the Mediterranean diet rich in olive oil does not contribute to obesity and appears to be a useful tool in the lifestyle management of the MetS. Moreover there is good scientific support for MUFA diets, especially those based on olive oil, as an alternative approach to low-fat diets for the medical nutritional therapy in diabetes. The objective of this review is to present evidence illustrating the relationship between Mediterranean diet, olive oil and metabolic diseases, including obesity, MetS and diabetes mellitus and to discuss potential mechanisms by which this food can help in disease prevention and treatment. |
| | |
Authors:
|
Pablo Pérez-Martínez; Antonio García-Ríos; Javier Delgado-Lista; Francisco Pérez-Jiménez; José López-Miranda |
Related Documents
:
|
971344 - Effect of the phospholipid vehicle on the transport of cholesterol in rats. 6303434 - Phospholipid fatty acid modification of rat liver microsomes affects acylcoenzyme a:cho... 3689204 - Effect of verapamil on cholesteryl ester hydrolysis and reesterification in macrophages. 16730694 - Importance of acyl-coenzyme a:cholesterol acyltransferase 1/2 dual inhibition for anti-... 20543554 - The effects of native and synthetic estrogenic compounds as well as vitamin d less-calc... 14531984 - Myiasis with lund's fly (cordylobia rodhaini) in travelers. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-3-28 |
Journal Detail:
|
Title: Current pharmaceutical design Volume: - ISSN: 1873-4286 ISO Abbreviation: - Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-3-29 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9602487 Medline TA: Curr Pharm Des Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Lipid and Atherosclerosis Unit. IMIBIC/Reina Sofia University Hospital/University of Cordoba, and CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Spain. jlopezmir@uco.es. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Olive Oil and Cancer Risk: An Update of Epidemiological Findings to 2010.
Next Document: Extra Virgin Olive Oil's Polyphenols: Biological Activities.